Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.
Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 900 million to optimise its capital structure.
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.
Vinge has acted as a Swedish local counsel to Krogerus in advising Caverion Oyj, one of the Europe's leading provider of technical solutions for buildings and industries, on its acquisition of Huurre Finland Oy, including its subsidiary Huurre Sweden AB.
Vinge has advised the hotel property owner Pandox in connection with a directed share issue of 16,350,000 class B shares, whereby Pandox will receive approximately SEK 3 billion in issue proceeds.
Vinge has advised FJ Dynamics, a leading global robotic company in the agricultural sector, in connection with its acquisition of Sveaverken Svea Agri.
Vinge is advising funds managed by Corsair Capital LLC on their acquisition of a controlling interest in Axo AS, a leading consumer credit and loan broker in Scandinavia and Finland.
